LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 80

Search options

  1. Article ; Online: Engineering U1-Based Tetracycline-Inducible Riboswitches to Control Gene Expression in Mammals.

    Rovira, Eric / Moreno, Beatriz / Razquin, Nerea / Blázquez, Lorea / Hernández-Alcoceba, Ruben / Fortes, Puri / Pastor, Fernando

    ACS nano

    2023  Volume 17, Issue 23, Page(s) 23331–23346

    Abstract: Synthetic riboswitches are promising regulatory devices due to their small size, lack of immunogenicity, and ability to fine-tune gene expression in the absence of exogenous trans-acting factors. Based on a gene inhibitory system developed at our lab, ... ...

    Abstract Synthetic riboswitches are promising regulatory devices due to their small size, lack of immunogenicity, and ability to fine-tune gene expression in the absence of exogenous trans-acting factors. Based on a gene inhibitory system developed at our lab, termed U1snRNP interference (U1i), we developed tetracycline (TC)-inducible riboswitches that modulate mRNA polyadenylation through selective U1 snRNP recruitment. First, we engineered different TC-U1i riboswitches, which repress gene expression unless TC is added, leading to inductions of gene expression of 3-to-4-fold. Second, we developed a technique called Systematic Evolution of Riboswitches by Exponential Enrichment (SEREX), to isolate riboswitches with enhanced U1 snRNP binding capacity and activity, achieving inducibilities of up to 8-fold. Interestingly, by multiplexing riboswitches we increased inductions up to 37-fold. Finally, we demonstrated that U1i-based riboswitches are dose-dependent and reversible and can regulate the expression of reporter and endogenous genes in culture cells and mouse models, resulting in attractive systems for gene therapy applications. Our work probes SEREX as a much-needed technology for the
    MeSH term(s) Animals ; Mice ; Riboswitch/genetics ; Ribonucleoprotein, U1 Small Nuclear/genetics ; Tetracycline/pharmacology ; Anti-Bacterial Agents ; Mammals/genetics ; Gene Expression
    Chemical Substances Riboswitch ; Ribonucleoprotein, U1 Small Nuclear ; Tetracycline (F8VB5M810T) ; Anti-Bacterial Agents
    Language English
    Publishing date 2023-11-16
    Publishing country United States
    Document type Journal Article
    ISSN 1936-086X
    ISSN (online) 1936-086X
    DOI 10.1021/acsnano.3c01994
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Application of a split-Cre system for high-capacity adenoviral vector amplification.

    Gonzalez-Aparicio, Manuela / Bunuales, Maria / de Landazuri, Iñaki Ortiz / Prieto, Jesus / Hernandez-Alcoceba, Ruben

    Biotechnology journal

    2022  Volume 18, Issue 3, Page(s) e2200227

    Abstract: Background and aims: High-capacity adenoviral vectors (HC-AdV) show extended DNA payload and stability of gene expression in vivo due to the absence of viral coding sequences. However, production requires methods to trans-complement viral proteins, ... ...

    Abstract Background and aims: High-capacity adenoviral vectors (HC-AdV) show extended DNA payload and stability of gene expression in vivo due to the absence of viral coding sequences. However, production requires methods to trans-complement viral proteins, usually through Helper Viruses (HV). The Cre/loxP system is frequently employed to remove the packaging signal in HV genomes, in order to avoid their encapsidation. However, chronic exposure to the Cre recombinase in packaging cells is detrimental. We have applied the dimerizable Cre system to overcome this limitation.
    Methods and results: Cre was split in two fragments devoid of recombinase function (N-terminal 244 and C-terminal 99 amino-acids). In one version of the system, interaction with both moieties was favored by rapamycin-dependent heterodimerization domains (DiCre). Other version contained only Cre sequences (oCre). We generated packaging cells and HVs expressing the complementary fragments and studied their performance for HC-AdV production. We found that both conformations avoided interference with the growth of packaging cells, and the oCre system was particularly suitable for HC-AdV amplification.
    Conclusions: The split-Cre system improves the performance of packaging cells and can reduce the time and cost of HC-AdV amplification up to 30% and 15%, respectively. This may contribute to the standardization of HC-AdV production.
    MeSH term(s) Adenoviridae/genetics ; Integrases/genetics ; Genetic Vectors/genetics ; Viral Proteins/genetics
    Chemical Substances Cre recombinase (EC 2.7.7.-) ; Integrases (EC 2.7.7.-) ; Viral Proteins
    Language English
    Publishing date 2022-12-12
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2221885-3
    ISSN 1860-7314 ; 1860-6768
    ISSN (online) 1860-7314
    ISSN 1860-6768
    DOI 10.1002/biot.202200227
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Recent advances in oncolytic virus design.

    Hernández-Alcoceba, Rubén

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

    2011  Volume 13, Issue 4, Page(s) 229–239

    Abstract: The cytolytic properties of viruses can be used to treat cancer. Replication of certain viruses is favoured in cancer cells, whereas others can be modified to obtain tumour specificity. This approach has evolved to become a new discipline called ... ...

    Abstract The cytolytic properties of viruses can be used to treat cancer. Replication of certain viruses is favoured in cancer cells, whereas others can be modified to obtain tumour specificity. This approach has evolved to become a new discipline called virotherapy. In addition, these replication-competent (oncolytic) viruses can be adapted as vectors for cancer gene therapy. The "armed" viruses show a double mechanism of action: direct destruction of cancer cells as a consequence of the lytic viral cycle, in combination with the effect of the therapeutic gene incorporated in the viral genome. Current trends in the field include strategies to increase the oncolytic potency of existing viruses; the evaluation of new candidates; the search for synergistic effects between different viruses and conventional therapies; and a rational approach to take advantage of the interplay between the viruses and the host immune system. This review summarises the most relevant achievements in recent years.
    MeSH term(s) Animals ; Humans ; Neoplasms/therapy ; Neoplasms/virology ; Oncolytic Virotherapy/trends ; Oncolytic Viruses/genetics
    Language English
    Publishing date 2011-03-05
    Publishing country Italy
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2397359-6
    ISSN 1699-3055 ; 1699-048X
    ISSN (online) 1699-3055
    ISSN 1699-048X
    DOI 10.1007/s12094-011-0647-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Cancer stem cell-associated microRNAs: searching for markers and targets in hepatocellular carcinoma.

    Hernandez-Alcoceba, Ruben / Fortes, Puri

    Translational gastroenterology and hepatology

    2016  Volume 1, Page(s) 16

    Language English
    Publishing date 2016-03-16
    Publishing country China
    Document type Journal Article ; Comment
    ISSN 2415-1289
    ISSN 2415-1289
    DOI 10.21037/tgh.2016.03.11
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by

    García, Marta / Bonafont, Jose / Martínez-Palacios, Jesús / Xu, Rudan / Turchiano, Giandomenico / Svensson, Stina / Thrasher, Adrian J / Larcher, Fernando / Del Rio, Marcela / Hernández-Alcoceba, Rubén / Garín, Marina I / Mencía, Ángeles / Murillas, Rodolfo

    Molecular therapy. Methods & clinical development

    2022  Volume 27, Page(s) 96–108

    Abstract: Recessive dystrophic epidermolysis bullosa, a devastating skin fragility disease characterized by recurrent skin blistering, scarring, and a high risk of developing squamous cell carcinoma is caused by mutations ... ...

    Abstract Recessive dystrophic epidermolysis bullosa, a devastating skin fragility disease characterized by recurrent skin blistering, scarring, and a high risk of developing squamous cell carcinoma is caused by mutations in
    Language English
    Publishing date 2022-09-16
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2872938-9
    ISSN 2329-0501 ; 2329-0501
    ISSN (online) 2329-0501
    ISSN 2329-0501
    DOI 10.1016/j.omtm.2022.09.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Alterations of the Hippocampal Neurogenic Niche in a Mouse Model of Dravet Syndrome.

    Martín-Suárez, Soraya / Abiega, Oihane / Ricobaraza, Ana / Hernandez-Alcoceba, Rubén / Encinas, Juan Manuel

    Frontiers in cell and developmental biology

    2020  Volume 8, Page(s) 654

    Abstract: Hippocampal neurogenesis, the process by which neural stem cells (NSCs) continuously generate new neurons in the dentate gyrus (DG) of most mammals including humans, is chiefly regulated by neuronal activity. Thus, severe alterations have been found in ... ...

    Abstract Hippocampal neurogenesis, the process by which neural stem cells (NSCs) continuously generate new neurons in the dentate gyrus (DG) of most mammals including humans, is chiefly regulated by neuronal activity. Thus, severe alterations have been found in samples from epilepsy patients and in the hippocampal neurogenic niche in mouse models of epilepsy. Reactive-like and gliogenic NSCs plus aberrant newborn neurons with altered migration, morphology, and functional properties are induced by seizures in experimental models of temporal lobe epilepsy. Hippocampal neurogenesis participates in memory and learning and in the control of anxiety and stress. It has been therefore hypothesized that part of the cognitive symptoms associated with epilepsy could be promoted by impaired hippocampal neurogenesis. We here analyze for the first time the alterations of the neurogenic niche in a novel mouse model of Dravet syndrome (DS), a genetic encephalopathy with severe epilepsy in infancy and multiple neurological comorbidities. Scn1a
    Language English
    Publishing date 2020-07-21
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2737824-X
    ISSN 2296-634X
    ISSN 2296-634X
    DOI 10.3389/fcell.2020.00654
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Viral vector-mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome.

    Fadila, Saja / Beucher, Bertrand / Dopeso-Reyes, Iria González / Mavashov, Anat / Brusel, Marina / Anderson, Karen / Ismeurt, Caroline / Goldberg, Ethan M / Ricobaraza, Ana / Hernandez-Alcoceba, Ruben / Kremer, Eric J / Rubinstein, Moran

    The Journal of clinical investigation

    2023  Volume 133, Issue 12

    Abstract: Dravet syndrome (DS), an intractable childhood epileptic encephalopathy with a high fatality rate, is typically caused by loss-of-function mutations in one allele of SCN1A, which encodes NaV1.1, a 250-kDa voltage-gated sodium channel. In contrast to ... ...

    Abstract Dravet syndrome (DS), an intractable childhood epileptic encephalopathy with a high fatality rate, is typically caused by loss-of-function mutations in one allele of SCN1A, which encodes NaV1.1, a 250-kDa voltage-gated sodium channel. In contrast to other epilepsies, pharmaceutical treatment for DS is limited. Here, we demonstrate that viral vector-mediated delivery of a codon-modified SCN1A open reading frame into the brain improves DS comorbidities in juvenile and adolescent DS mice (Scn1aA1783V/WT). Notably, bilateral vector injections into the hippocampus and/or the thalamus of DS mice increased survival, reduced the occurrence of epileptic spikes, provided protection from thermally induced seizures, corrected background electrocorticographic activity and behavioral deficits, and restored hippocampal inhibition. Together, our results provide a proof of concept for the potential of SCN1A delivery as a therapeutic approach for infants and adolescents with DS-associated comorbidities.
    MeSH term(s) Mice ; Animals ; NAV1.1 Voltage-Gated Sodium Channel/genetics ; NAV1.1 Voltage-Gated Sodium Channel/metabolism ; Epilepsies, Myoclonic/genetics ; Epilepsies, Myoclonic/therapy ; Seizures/genetics ; Seizures/metabolism ; Hippocampus/metabolism ; Mutation
    Chemical Substances NAV1.1 Voltage-Gated Sodium Channel
    Language English
    Publishing date 2023-06-15
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI159316
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy.

    Ricobaraza, Ana / Gonzalez-Aparicio, Manuela / Mora-Jimenez, Lucia / Lumbreras, Sara / Hernandez-Alcoceba, Ruben

    International journal of molecular sciences

    2020  Volume 21, Issue 10

    Abstract: The adaptation of adenoviruses as gene delivery tools has resulted in the development of high-capacity adenoviral vectors (HC-AdVs), also known, helper-dependent or "gutless". Compared with earlier generations (E1/E3-deleted vectors), HC-AdVs retain ... ...

    Abstract The adaptation of adenoviruses as gene delivery tools has resulted in the development of high-capacity adenoviral vectors (HC-AdVs), also known, helper-dependent or "gutless". Compared with earlier generations (E1/E3-deleted vectors), HC-AdVs retain relevant features such as genetic stability, remarkable efficacy of in vivo transduction, and production at high titers. More importantly, the lack of viral coding sequences in the genomes of HC-AdVs extends the cloning capacity up to 37 Kb, and allows long-term episomal persistence of transgenes in non-dividing cells. These properties open a wide repertoire of therapeutic opportunities in the fields of gene supplementation and gene correction, which have been explored at the preclinical level over the past two decades. During this time, production methods have been optimized to obtain the yield, purity, and reliability required for clinical implementation. Better understanding of inflammatory responses and the implementation of methods to control them have increased the safety of these vectors. We will review the most significant achievements that are turning an interesting research tool into a sound vector platform, which could contribute to overcome current limitations in the gene therapy field.
    MeSH term(s) Adenoviridae/genetics ; Adenoviridae/immunology ; Animals ; Drug Therapy/methods ; Genetic Vectors/adverse effects ; Genetic Vectors/genetics ; Genetic Vectors/standards ; Genomic Instability ; Humans
    Keywords covid19
    Language English
    Publishing date 2020-05-21
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms21103643
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Gene therapies and COVID-19 vaccines: a necessary discussion in relation with viral vector-based approaches.

    Aledo-Serrano, Angel / Gil-Nagel, Antonio / Isla, Julian / Mingorance, Ana / Mendez-Hermida, Fernando / Hernandez-Alcoceba, Ruben

    Orphanet journal of rare diseases

    2021  Volume 16, Issue 1, Page(s) 316

    Abstract: The COVID-19 pandemic is adding an unanticipated concern for those affected by genetic diseases. Most of the new treatment achievements for these patients are made possible as a result of advances in viral-based products. Among them, adenoviruses (AdV) ... ...

    Abstract The COVID-19 pandemic is adding an unanticipated concern for those affected by genetic diseases. Most of the new treatment achievements for these patients are made possible as a result of advances in viral-based products. Among them, adenoviruses (AdV) and especially adeno-associated viruses (AAV) are important players. The concerns and the conversation around this issue have increased as COVID-19 vaccines approach the market. What if the viral vectors become the mainstream strategy for vaccine development? Will the immune response elicited against the vector compromise the efficacy of future gene therapies? Patients with genetic diseases and patient advocacy groups are requesting information to the medical community about the potential impact of these vaccines in future gene therapy treatments, and physicians and scientists are not able to provide satisfactory answer yet. Importantly, the frequency of cross-reactivity among different AAV serotypes can be as high as 50%. This would have potential implications for patients with genetic disorders who could benefit from gene therapies, often coming in the form of AAV-based gene therapies. As in many other aspects, this pandemic is challenging our capacity to coordinate, plan ahead and align different medical objectives. In this case, having such conversation early on might allow us to make the right choices while we are still on time.
    MeSH term(s) COVID-19 ; COVID-19 Vaccines ; Genetic Therapy ; Humans ; Pandemics ; SARS-CoV-2
    Chemical Substances COVID-19 Vaccines
    Language English
    Publishing date 2021-07-16
    Publishing country England
    Document type Letter
    ZDB-ID 2225857-7
    ISSN 1750-1172 ; 1750-1172
    ISSN (online) 1750-1172
    ISSN 1750-1172
    DOI 10.1186/s13023-021-01958-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Understanding the Potential Role of Sirtuin 2 on Aging: Consequences of SIRT2.3 Overexpression in Senescence.

    Sola-Sevilla, Noemi / Ricobaraza, Ana / Hernandez-Alcoceba, Ruben / Aymerich, Maria S / Tordera, Rosa M / Puerta, Elena

    International journal of molecular sciences

    2021  Volume 22, Issue 6

    Abstract: Sirtuin 2 (SIRT2) has been associated to aging and age-related pathologies. Specifically, an age-dependent accumulation of isoform 3 of SIRT2 in the CNS has been demonstrated; however, no study has addressed the behavioral or molecular consequences that ... ...

    Abstract Sirtuin 2 (SIRT2) has been associated to aging and age-related pathologies. Specifically, an age-dependent accumulation of isoform 3 of SIRT2 in the CNS has been demonstrated; however, no study has addressed the behavioral or molecular consequences that this could have on aging. In the present study, we have designed an adeno-associated virus vector (AAV-CAG-Sirt2.3-eGFP) for the overexpression of SIRT2.3 in the hippocampus of 2 month-old SAMR1 and SAMP8 mice. Our results show that the specific overexpression of this isoform does not induce significant behavioral or molecular effects at short or long term in the control strain. Only a tendency towards a worsening in the performance in acquisition phase of the Morris Water Maze was found in SAMP8 mice, together with a significant increase in the pro-inflammatory cytokine Il-1β. These results suggest that the age-related increase of SIRT2.3 found in the brain is not responsible for induction or prevention of senescence. Nevertheless, in combination with other risk factors, it could contribute to the progression of age-related processes. Understanding the specific role of SIRT2 on aging and the underlying molecular mechanisms is essential to design new and more successful therapies for the treatment of age-related diseases.
    MeSH term(s) Aging/metabolism ; Animals ; Astrocytes/metabolism ; Behavior, Animal ; Gene Expression Regulation, Developmental ; Hippocampus/metabolism ; Hippocampus/pathology ; Inflammation/pathology ; Mice, Inbred C57BL ; Microglia/metabolism ; Neurodegenerative Diseases/metabolism ; Sirtuin 2/genetics ; Sirtuin 2/metabolism ; Mice
    Chemical Substances Sirtuin 2 (EC 3.5.1.-)
    Language English
    Publishing date 2021-03-18
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms22063107
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top